Overview

Study to Assess Patient Reported Outcomes With Armodafinil Treatment for Excessive Sleepiness in Adults With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome

Status:
Completed

Trial end date:
2006-07-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess patient reported outcomes with armodafinil treatment in terms of improvement in sleepiness, satisfaction with treatment, impact on ability to engage in life activities (ie, daily or work and family and/or social activities), and effects on fatigue. Clinician ratings on patient response to armodafinil treatment will also be assessed.

Phase:

Phase 3

Details

Lead Sponsor:

Cephalon

Treatments:

Armodafinil
Modafinil